PubRank

N Giuliani

Author PubWeight™ 21.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 1996 1.68
2 Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia 2005 1.63
3 Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction. Leukemia 2013 1.21
4 Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med 1998 1.20
5 The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost 1998 1.13
6 Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells. Leukemia 2010 1.12
7 Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 2000 1.03
8 The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol 1998 1.02
9 PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol 1998 0.99
10 HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia 2010 0.95
11 An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 1997 0.93
12 Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 1999 0.87
13 Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol 1997 0.87
14 Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996 0.86
15 Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Clin Endocrinol (Oxf) 1999 0.84
16 Clinical observations with a new specific assay for bone alkaline phosphatase: a cross-sectional study in osteoporotic and pagetic subjects and a longitudinal evaluation of the response to ovariectomy, estrogens, and bisphosphonates. Calcif Tissue Int 1996 0.80
17 Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells. Leukemia 2012 0.79
18 Different effects of naloxone on the growth hormone response to melatonin and pyridostigmine in normal men. Metabolism 1998 0.79
19 Arginine vasopressin and oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men. Metabolism 1998 0.78
20 Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients. Leukemia 2010 0.77
21 Interleukin-6: a pathogenetic role in the postmenopausal osteoporosis? Acta Biomed Ateneo Parmense 1995 0.76
22 Stimulation of ACTH and GH release by angiotensin II in normal men is mediated by the AT1 receptor subtype. Regul Pept 1998 0.76
23 Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics. J Intern Med 1998 0.75
24 Effect of melatonin on arginine vasopressin secretion stimulated by physical exercise or angiotensin II in normal men. Neuropeptides 1998 0.75
25 [Comparative evaluation of several methods of determining anti-streptolysin O]. Quad Sclavo Diagn 1980 0.75
26 The use of frozen-thawed platelet-derived phospholipids as a confirmatory test for the diagnosis of lupus anticoagulants. Comparison with two commercial confirmatory system tests. Thromb Res 1999 0.75
27 The possible role of hematin and Mössbauer effect in the inhibition of osteosarcoma cell proliferation. Anticancer Res 1999 0.75
28 Detection of the factor V Leiden using SSCP. Thromb Haemost 1996 0.75
29 5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. J Endocrinol Invest 1998 0.75
30 Identifying human platelet glycoproteins IIb and IIIa by capillary electrophoresis. Electrophoresis 1998 0.75
31 Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation. Leukemia 2006 0.75
32 Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon alpha therapy. J Investig Med 1996 0.75
33 Melatonin inhibits oxytocin response to insulin-induced hypoglycemia, but not to angiotensin II in normal men. J Neural Transm (Vienna) 1998 0.75
34 [Rectosigmoid junction neoplasms: our experience]. G Chir 2004 0.75
35 [The physiopathology of osteoporosis: the role of local factors]. Ann Ital Med Int 1995 0.75